全球一次性胰岛素泵市场规模、份额和趋势分析报告 – 行业概况和 2031 年预测

一次性胰岛素泵市场分析  

一次性胰岛素泵市场正在经历显着增长，这得益于糖尿病患病率的上升和对创新、用户友好型设备的需求不断增长。预计到 2030 年，全球糖尿病人口将达到 6.43 亿，对有效胰岛素输送系统的需求比以往任何时候都更加迫切。市场的最新发展包括推出先进的一次性胰岛素泵，该泵具有集成的连续血糖监测 (CGM) 系统，可增强血糖管理并为用户提供实时数据。公司专注于以用户为中心的设计，例如无管和轻量级型号，以提高便利性并减轻管理糖尿病的负担。此外，新的一次性胰岛素输送系统的监管批准，例如最近 FDA 批准了几种尖端产品，正在扩大市场准入并增强消费者信心。科技公司和医疗保健提供商之间的合作也在加速创新，从而开发出可与移动应用程序连接的智能胰岛素泵，以更好地管理糖尿病。随着人们对糖尿病管理的认识不断提高，一次性胰岛素泵市场有望实现强劲增长，从而提高糖尿病患者的生活质量。

一次性胰岛素泵市场规模

2023 年全球一次性胰岛素泵市场规模价值 35.7 亿美元，预计到 2031 年将达到 65 亿美元，2024 年至 2031 年预测期内的复合年增长率为 7.77%。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的见解外，Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、管道分析、定价分析和监管框架。

一次性胰岛素泵市场趋势

“提高智能技术集成度”

The disposable insulin pumps market is gaining traction as patients seek convenient and cost-effective solutions for diabetes management. A prominent trend in the  market is the increasing shift towards smart technology integration, enhancing the functionality and user experience of these devices. These advanced insulin pumps now often feature wireless connectivity, allowing patients to monitor their glucose levels and manage insulin delivery through smartphone applications. For instance, devices such as Omnipod DASH have gained traction by providing a tubeless design with real-time data tracking, which improves patient adherence and ease of use. As diabetes management becomes more personalized, the demand for disposable insulin pumps with advanced features, such as automated insulin dosing and data sharing with healthcare providers, is rising. Such trend highlights the growing importance of technology in providing effective and convenient treatment options for patients with diabetes.

Report Scope and Disposable Insulin Pumps Market Segmentation  

Disposable Insulin Pumps Market Definition

Disposable insulin pumps are compact, portable devices designed to deliver precise doses of insulin to individuals with diabetes, they are designed for single-use and come pre-filled with insulin. These pumps often feature user-friendly interfaces and are equipped with technology to facilitate easy insulin administration, helping to manage blood glucose levels effectively. They may also include advanced functionalities, such as integration with continuous glucose monitoring systems, enabling real-time glucose tracking and automated insulin delivery. T Their ease of use and convenience make disposable insulin pumps a popular choice for patients looking for a straightforward way to manage their diabetes.

Disposable Insulin Pumps Market Dynamics

Drivers

• Rising Prevalence of Diabetes

The rising prevalence of diabetes is a significant driver for the disposable insulin pumps market, as the increasing global incidence of both type 1 and type 2 diabetes necessitates effective insulin delivery systems. According to the International Diabetes Federation, over 537 million adults were living with diabetes in 2021, and this number is projected to reach 783 million by 2045. This alarming trend underscores the urgent need for innovative diabetes management solutions, including disposable insulin pumps that offer convenience and precision in insulin delivery. As the population of diabetes patients continues to grow, particularly in regions such as Asia-Pacific where the prevalence is rapidly increasing, the demand for disposable insulin pumps is expected to expand significantly, creating lucrative opportunities for manufacturers and healthcare providers in this evolving market.

• Rising Global Aging Population

The global aging population significantly influences the demand for easy-to-use insulin delivery devices, as older adults are more prone to diabetes and its associated complications. According to the World Health Organization (WHO), the number of people aged 60 and older is expected to reach 2.1 billion by 2050, representing a substantial increase from 1 billion in 2019. Such demographic shift is accompanied by a higher prevalence of diabetes, with estimates suggesting that approximately 10% of older adults are living with the condition. As managing diabetes becomes increasingly complex with age, there is a growing need for user-friendly insulin delivery systems, such as disposable insulin pumps, that offer simplicity and convenience.  Consequently, the demand for such solutions is expected to rise as healthcare providers aim to enhance the quality of life for older adults living with diabetes, ultimately driving the market.

Opportunities

• Rising Technological Advancements

Technological advancements in disposable insulin pump technology are significantly enhancing patient experiences through the incorporation of smart features such as remote monitoring and automated insulin delivery systems. For instance, the Medtronic MiniMed 770G system integrates continuous glucose monitoring (CGM) with an insulin pump, allowing for automated insulin delivery adjustments based on real-time glucose readings. This closed-loop system simplifies diabetes management for patients and helps maintain optimal glucose levels, reducing the risk of hypoglycemia. Furthermore, companies that focus on developing advanced algorithms and connectivity features, such as those that enable seamless integration with mobile applications, are poised to capitalize on this trend. As technology continues to evolve, these innovations represent substantial opportunities for companies to improve diabetes management and enhance patient adherence to treatment protocols.

• Increasing Healthcare Expenditure

Increased healthcare expenditure, especially in developed regions, plays a crucial role in fostering the adoption of advanced medical devices, such as disposable insulin pumps. According to the Centers for Medicare & Medicaid Services (CMS), U.S. healthcare spending is projected to grow at an average rate of 5.4% annually, reaching approximately USD 6 trillion by 2027. Such surge in investment enhances access to innovative diabetes management solutions, as healthcare systems prioritize funding for technologies that improve patient outcomes and streamline care. For instance, initiatives that reimburse patients for the use of modern insulin delivery systems, including disposable insulin pumps, are becoming more common, allowing for broader access among diabetic patients. As a result, the growth in healthcare expenditure is directly correlated with improved access to effective diabetes care solutions, ultimately creating opportunities in the market.

Restraints/Challenges

• High Equipment Costs

The high cost of disposable insulin pumps serves as a significant market challenge, particularly for patients in regions with limited insurance coverage or considerable out-of-pocket expenses. As disposable insulin pumps can be prohibitively expensive, they become inaccessible to individuals with lower incomes or inadequate insurance plans. Consequently, many patients may opt for less expensive alternatives, such as traditional insulin syringes or pens, which, although effective, fail to provide the same level of convenience and efficiency in diabetes management. Such financial burden hinders the adoption of advanced insulin delivery systems and contributes to poorer health outcomes, as individuals unable to afford these technologies may struggle to maintain optimal blood glucose levels, thereby increasing their risk of diabetes-related complications.

• Limited Equipment Awareness

Limited awareness of disposable insulin pumps presents a notable challenge in their adoption, as both patients and healthcare providers may not fully understand the availability and benefits of these innovative devices. Despite their advantages, such as ease of use and improved diabetes management, many individuals continue to rely on traditional methods due to a lack of information. Such gap in awareness can result in missed opportunities for better glycemic control and overall health outcomes, as patients may struggle with the more cumbersome traditional methods. In addition, healthcare providers in these areas may not prioritize educating their patients about the latest technologies, further hampering the overall market expansion.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Disposable Insulin Pumps Market Scope

The market is segmented on the basis of type, products, accesories and end-users. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Patch pumps
• Tethered pumps

Product

• MiniMed
• Accu-Chek
• Tandem
• Omnipod
• others

Accessories

• Insulin Eeservoir or Cartridges
• Insulin Set Insertion Devices
• Battery

End-Users

• Hospitals and Clinics
• Home Care
• Laboratories

Disposable Insulin Pumps Market Regional Analysis

The market is analysed and market size insights and trends are provided by country, type, products, accesories and end-users as referenced above.

The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America stands out as the leading region in the market, primarily due to its well-established healthcare and medical facilities that ensure comprehensive patient care. The presence of major medical manufacturers and key players further enhances the region's dominance, facilitating innovation and access to advanced medical technologies. In addition, high healthcare expenditure in North America supports ongoing research and development, driving growth in the medical market.

Asia-Pacific region is projected to experience substantial growth during the forecast period from 2024 to 2031, largely driven by the rising prevalence of diabetes. As lifestyle changes and an aging population contribute to increasing diabetes rates, there is a growing demand for effective management and treatment solutions. This surge in demand is prompting healthcare providers and stakeholders in the region to invest in innovative diabetes care technologies and services, further fueling market expansion.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.  

Disposable Insulin Pumps Market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

Disposable Insulin Pumps Market Leaders Operating in the Market Are:

• Medtronic (U.S.)
• Insulet Corporation (U.S.)
• F. Hoffmann-La Roche Ltd (Switzerland)
• SOOIL Developments Co., Ltd (South Korea)
• Tandem Diabetes Care, Inc. (U.S.)
• SHINMYUNG MEDIYES CO., LTD. (South Korea)
• Debiotech SA (Switzerland)
• TOP Corporation (Japan)
• Kingfa Sci.&Tech. Co., Ltd (China)
• Sphere Fluidics (U.K.)
• Medsolve (UK) Limited (U.K.)
• Sanofi (France)
• Abbott (U.S.)
• BD (U.S.)

Latest Developments in Disposable Insulin Pumps Market

• 2024 年 9 月，拥有百年胰岛素输送历史的糖尿病护理全球领导者 Embecta Corp. 宣布其创新型一次性胰岛素输送系统已获得美国食品药品监督管理局 (FDA) 的 510(k) 批准。该系统专为管理糖尿病（包括 1 型糖尿病 (T1D) 和 2 型糖尿病 (T2D)）的成年人设计，采用无管贴片泵设计，配备 300 个单位的胰岛素储液器，是根据 2 型糖尿病患者及其医疗保健提供者的见解开发的
• 2024 年 3 月，FDA 批准了 twiist 自动胰岛素输送 (AID) 系统，标志着它成为首个与 Tidepool Loop 集成的胰岛素泵。twiist AID 系统已获准用于 6 岁及以上的 1 型糖尿病患者，与 Tidepool Loop 结合使用，可提供精确的微剂量功能，允许用户将目标剂量设定为低至 87 mg/dL，并根据各种食物类型提供推注选项
• 2024 年 1 月，全球医疗技术领域的领跑者美敦力公司宣布，其 MiniMed™ 780G 系统已获得 CE（欧洲认证）标志认证，该系统包括 Simplera Sync，这是一款一次性的一体式连续血糖监测仪 (CGM)，无需指尖采血或胶带粘贴。Simplera Sync 通过简单的两步插入过程提供增强的用户体验，尺寸只有早期美敦力传感器的一半
• 2023 年 12 月，美敦力取消了收购 EOFlow 的计划，EOFlow 是一家生产胰岛素贴片泵的公司，目前与 Insulet 存在专利纠纷。美敦力以“多次违反”两家公司之间的协议为由做出这一决定。今年，EOFlow 一直面临与 Insulet 的专利诉讼
• 2023 年 5 月，Embecta 与 Tidepool 合作开发一款旨在增强糖尿病管理的创新型胰岛素泵。这一战略联盟旨在将先进技术和用户友好功能融入设备，改善患者治疗效果。此外，Embecta 上调了第二季度的增长预期，反映出对其产品线和市场需求的信心

SKU-63894